Unified Brainz is resolute in presenting and celebrating the exemplary careers of some of the most stalwart personalities whose fortitude, assiduousness and willpower have made them claim the highest level of glory. This year again, we are proud to present one more limited edition of the unique dark mode Coffee Table Book, “Who’s Who of The Industry”, which is marked in the World Book of Records, London, where we have handpicked the success stories of individuals who have made an inedible mark in their respective industries and emerged as victorious leaders.
Poorvank Purohit is an accomplished and performance-driven pharmaceutical professional with extensive experience in the industry. Holding positions at top pharmaceutical companies such as Ranbaxy (Sun Pharma), Jubilant, Alembic Pharmaceuticals, Hikal Limited, RL Fine Chem, and now with Solara Active Pharma Sciences, Poorvank has garnered exceptional expertise in both APIs (Active Pharmaceutical Ingredients) and Finished Products. Being at Solara, Poorvank is one of the youngest minds in the pharmaceutical space to lead a Public listed entity as Managing Director and Chief Executive Officer. Solara is one of the largest pure-play API companies globally and one of the largest API manufacturers of Ibuprofen medicine worldwide, with exports to more than 75 countries worldwide. Poorvank’s expertise spans various areas, including corporate strategy, sales and business development, talent acquisition, operations management, and project management, to name a few.
An alumnus of Wharton Business School, University of Pennsylvania, US and Indian Institute of Management, Bangalore, Poorvank also holds a degree in Chemical Engineering from MS Ramaiah Institute of Technology, Bangalore (MSRIT). Poorvank’s journey has been truly inspiring and marked by remarkable achievements. He has traveled to over 45 countries, establishing strong networks and relationships with decision-makers at innovator and generic companies across the globe.
To put things in perspective, the significance of this industry was especially highlighted during Covid times when the security of the supply chain became the most critical agenda for economies across the globe. “No medicine can be made without an API/ Bulk Drug,” he says. Solara supplies its APIs to large innovator and generic companies across markets such as the US, Europe, Latin America, the Middle East, Asia Pacific, Africa, and CIS.
Poorvank’s career at R L Fine Chem Pvt. Ltd. began in 2018 when he became the Chief Operations Officer (COO). The company, based in Bengaluru, specializes in manufacturing niche APIs in the CNS (Central Nervous System) category, including psychotropic substances.
Poorvank introduced several value-creation initiatives at RL Fine Chem. These included optimizing the Product mix, backward integration, market expansion, and most importantly, building the right team to drive growth. Poorvank invested time in getting the right people on board and helping team members realize their potential. Poorvank raised the bar and achieved significant milestones within five years. Poorvank’s team also identified opportunities in the pharmaceutical industry, particularly in the supply gap for raw materials created by environmental challenges in China. R L Fine Chem capitalized on this opportunity by quickly backward integrating critical raw materials, ensuring self-sufficiency and market advantage. Under his leadership, R L Fine Chem has been nominated four times for the “API Supplier of the Year” category in the Global Generics Bulletin Awards, a top-tier award for Pharma Industry.
As the Managing Director and CEO of Solara, Poorvank emphasizes the importance of a collaborative approach and cross-functional teamwork. He believes in driving a problem-solving approach through collaboration, trust, and facilitation. For Poorvank, building long-lasting trust and relationships with customers is a priority. He understands their requirements, manages expectations, and provides high-quality products and exceptional customer service.
In his role as CEO, Poorvank finds utmost satisfaction in driving initiatives to make an impact and create value for all its shareholders.
Looking ahead, Poorvank remains committed to further elevating Solara’s position in the global pharmaceutical market. He envisions leveraging the company’s strengths in API manufacturing and expanding its product offerings to cater to evolving customer needs.
Poorvank’s passion for excellence and ability to drive positive change has earned him a reputation as a turnaround specialist in the pharmaceutical industry. His leadership style, characterized by transparency, empathy, and a focus on collaboration, has helped him build strong relationships with stakeholders, including customers, suppliers, and employees. To know more about Poorvank, check https://whoswho.world/ or to nominate email, [email protected]